Episode 251: Low-Risk MDS: What To Do?

Paolo Tarantino, MD, PhD, medical oncologist at Dana-Farber Cancer Institute, joins Chadi for a deep dive into the rapidly evolving world of antibody-drug conjugates (ADCs)—sometimes dubbed “super-chemotherapies.” He traces the fascinating origins of the ADC concept, including a ...  Show more

Chadi sits down with Nora Disis, MD—Editor in Chief of JAMA Oncology and professor at Fred Hutchinson Cancer Center—for a candid, wide-ranging discussion on the modern state of peer review and medical publishing. Dr. Disis reflects on the founding of JAMA Oncology and her role as ...  Show more

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/?utm_s ...

Despite progressive policy strides in health care reform, immigrant communities continue to experience stark disparities across the United States. In Not All In: Race, Immigration, and Health Care Exclusion in the Age of Obamacare (Johns Hopkins UP, 2025), Tiffany D. Joseph expos ...  Show more

Although President Obama signed it into law in March of 2010, the Affordable Care Act remains one of the nation’s most divisive issues. Over the past nearly four years, House Republicans have voted 40 times to repeal the law in part or in whole. Just this week, Senator Ted Cruz s ...  Show more

Healthcare is a constant concern in America and even more so during the coronavirus pandemic. There's a lot of uncertainty around healthcare right now -- it's a pivotal election year, the fate of the Affordable Care Act is not clear, and now, doctors are speaking out against some ...  Show more